The Scientist

» technology, neuroscience and microbiology

Most Recent

image: Pioneering Memory Researcher Dies

Pioneering Memory Researcher Dies

By | May 31, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Antibiotic Affects Cow Dung

Antibiotic Affects Cow Dung

By | May 25, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

3 Comments

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Narrow-Spectrum Antibiotic Could Spare the Microbiome

Narrow-Spectrum Antibiotic Could Spare the Microbiome

By | May 9, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Most Gut Microbes Can Be Cultured

Most Gut Microbes Can Be Cultured

By | May 4, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Earth: Home to 1 Trillion Microbial Species

Earth: Home to 1 Trillion Microbial Species

By | May 4, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Cellular Pruning Follows Adult Neurogenesis

Cellular Pruning Follows Adult Neurogenesis

By | May 2, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Animal Magnetism

Animal Magnetism

By | May 1, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

image: Becoming Acculturated

Becoming Acculturated

By | May 1, 2016

Suzanne Corkin, who studied the famous patient “H.M.,” has passed away at 79.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech